This calculator computes adjusted body weight (AjBW) as ideal body weight + 0.4 × (actual − ideal). Use AjBW in the Cockcroft-Gault creatinine clearance equation when actual weight is more than 130% of ideal body weight, because total body weight overestimates clearance in that range.
What Is Adjusted Body Weight?
Adjusted body weight (AjBW) is a dosing weight for obese patients that sits between ideal and total body weight. Total body weight overstates the size of the compartment that clears many drugs, because adipose tissue contributes far less to creatinine production and drug handling than lean mass. Plugging total body weight into the Cockcroft-Gault creatinine clearance equation therefore overestimates clearance in obesity. AjBW corrects for this by adding back only part of the excess weight.
The Adjusted Body Weight Formula
The formula is AjBW = IBW + 0.4 × (actual − IBW). In it, IBW is ideal body weight from the Devine formula, actual is the patient's total (measured) body weight, and the difference (actual − IBW) is the excess weight above ideal. The 0.4 factor adds back 40% of that excess, because adipose tissue makes only a limited contribution. The result always falls between IBW and actual weight.
Worked Example
Take a patient with an ideal body weight of 70 kg and an actual weight of 120 kg. The excess is 120 − 70 = 50 kg. AjBW = 70 + 0.4 × 50 = 70 + 20 = 90 kg. You would enter 90 kg, not 120 kg, as the weight in the Cockcroft-Gault equation. That keeps fat mass from inflating the creatinine clearance estimate.
When to Use Adjusted Body Weight
Use AjBW when actual weight is more than 130% of ideal body weight. The full rule for choosing a dosing weight is:
| Actual weight | Weight to use |
|---|---|
| Below IBW | actual (total) body weight |
| From IBW up to 130% of IBW | ideal body weight (IBW) |
| More than 130% of IBW | adjusted body weight (AjBW) |
The evidence for this rule comes from Winter and colleagues (2012), who compared Cockcroft-Gault estimates with measured 24-hour creatinine clearance in 3,678 patients. Actual body weight gave an unbiased estimate in underweight patients, and ideal body weight gave an unbiased estimate in patients of normal weight. Adjusted body weight with the 0.4 factor was the least biased and most accurate option in overweight, obese, and morbidly obese patients. The FDA 2024 guidance on pharmacokinetics in renal impairment agrees. It states that in overweight or obese people, using ideal or adjusted body weight in Cockcroft-Gault is likely to estimate kidney function more accurately than actual body weight.
The cut point is not universal. Some hospitals switch to AjBW at 120% of IBW rather than 130%, and trial protocols and drug labels can set their own rule, which then takes priority. SWOG Policy 38, for example, uses the patient's weight in Cockcroft-Gault but caps it at 140% of IBW. Record which rule you applied. See creatinine clearance in obesity for the full discussion.
Limitations and Edge Cases
- Not for normal-weight patients: from IBW up to 130% of IBW, the rule uses IBW itself, which gave an unbiased estimate in normal-weight patients.
- The 0.4 factor is an approximation: it was the least biased factor in the 2012 evaluation, but it is a convention rather than an exact physiological constant, and some agents use different correction factors.
- Requires a valid IBW: AjBW depends on Devine IBW, which is not validated below 5 feet of height.
- Acute kidney injury or non-steady state: the weight correction does not fix the fact that Cockcroft-Gault assumes a stable serum creatinine.
- Drug-specific dosing: some drugs specify total or lean body weight regardless of obesity; always check the drug label.
Why Adjusted Body Weight Works
Creatinine is produced mainly by muscle, so the kidneys' apparent ability to clear it scales with lean mass more than with fat. In an obese patient, total body weight is dominated by adipose tissue that adds little to creatinine production or to the clearance of many drugs. Plug total body weight into the Cockcroft-Gault equation and the estimate is credited with clearance the kidneys do not actually provide. Using ideal body weight alone has the opposite problem and can underestimate, because a heavier person does carry some extra lean mass and a larger filtering surface. Adjusted body weight is the compromise. It starts from IBW and adds back a fraction of the excess, so the weight input reflects the part of the extra mass that is metabolically active.
How the 0.4 Factor Is Chosen
The 0.4 coefficient means 40% of the weight above ideal is counted toward the dosing weight. It is a long-standing clinical convention rather than an exact physiological constant. It approximates the share of excess body mass that behaves like lean tissue for drug distribution and clearance. In the 2012 comparison against measured creatinine clearance, AjBW with the 0.4 factor was the least biased choice for overweight and obese patients. Some agents and protocols use a different factor, so treat the value as a sensible default rather than a fixed rule. Because AjBW always lies between IBW and actual weight, it never exceeds total body weight or falls below the lean reference.
Comparison Across Body Sizes
Worked through for a fixed 70 kg ideal body weight, the adjustment grows with the degree of excess:
| Actual weight | Actual as % of IBW | Excess over IBW | AjBW | Weight used in Cockcroft-Gault |
|---|---|---|---|---|
| 85 kg | 121% | 15 kg | 76 kg | 70 kg (IBW) |
| 100 kg | 143% | 30 kg | 82 kg | 82 kg (AjBW) |
| 120 kg | 171% | 50 kg | 90 kg | 90 kg (AjBW) |
| 150 kg | 214% | 80 kg | 102 kg | 102 kg (AjBW) |
In each row the AjBW sits between the 70 kg ideal and the actual weight and climbs slowly as the excess rises. That slow climb keeps the creatinine clearance estimate realistic rather than inflated. The 130% cut point for a 70 kg IBW is 91 kg, so the 85 kg patient stays on IBW. A hospital using a 120% cut point (84 kg) would move that patient to AjBW.
Putting AjBW to Work in Cockcroft-Gault
The practical workflow is short. First, calculate ideal body weight from the patient's height and sex. Next, compare it with the measured actual weight. If actual weight is below IBW, use actual weight. If it is from IBW up to 130% of IBW, use IBW. If it is more than 130% of IBW, calculate adjusted body weight with the 0.4 rule, unless a protocol or drug label sets a different rule. Then enter that chosen weight, not necessarily the number on the scale, into the Cockcroft-Gault creatinine clearance equation along with age, sex, and serum creatinine. Choosing the weight deliberately keeps the clearance estimate, and any drug dose derived from it, appropriate for the patient's actual physiology rather than inflated by body fat. See creatinine clearance in obesity for the full clinical discussion.
Why Not Just Use Total Body Weight?
Total body weight systematically overstates clearance in obesity, even though the number on the scale is the tempting input. Fat tissue is not metabolically inert, yet it produces little creatinine and contributes little to the clearance of most renally eliminated drugs. Counting it in full therefore credits the kidneys with work they are not doing. The result is an inflated creatinine clearance and, downstream, a drug dose that may be too high for the patient's true physiology. Adjusted body weight is designed to prevent that error while still counting the extra lean mass and larger filtering surface that a heavier person carries.